CRS Report for CongressPrepared for Members and Committees of Congress FDA Guidance Regarding the Promotion of Off-Label Uses of Drugs: Legal Issues -name redacted- Legislative Attorney March 19, 2009 Congressional Research Service 7-. www.crs.gov R40458
升级VIP 